Prostacyclin and the fibrinolytic system in ischemic vascular disease

This publication has 11 references indexed in Scilit:

• Interaction of Plasminogen Activators and Inhibitors with Plasminogen and Fibrin
  Seminars in Thrombosis and Hemostasis, 1982
• The Euglobulin Clot Lysis Time, a Rapid and Sensitive Method for the Assay of Fibrinolytic Activity after Venous Stasis
  Scandinavian Journal of Haematology, 1981
• Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
  Circulation, 1981
• A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease
  Thrombosis Research, 1981
• Haemodynamic changes induced by prostacyclin in man.
  Heart, 1980
• α2-antiplasmin consumption and fibrinogen breakdown during thrombolytic therapy
  Thrombosis Research, 1979
• Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men
  Pharmacological Research Communications, 1978
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976
• Increase in Fibrinogen and Fibrin-Related Antigen in Human Serum Due to In Vitro Lysis of Fibrin by Thrombin
  Journal of Clinical Investigation, 1972